Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Environ Sci Pollut Res Int ; 30(17): 49108-49124, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-36773254

RESUMEN

The leaves of Ficus johannis Boiss (F. johannis), commonly known as Fig tree, Anjir, and Teen, are used by the folk medicinal practitioners in Iran for controlling hyperglycemia in diabetic patients. This study investigated the pharmacological basis for antidiabetic effect of the ethanolic extract of F. johannis leaves using in vitro and in vivo experimental models. Qualitative screening of phytochemicals, estimation of total phenolic and flavonoid contents, and in vitro antioxidant and α-amylase inhibition assays were performed. Moreover, the High-performance liquid chromatography (HPLC) quantification, acute toxicity, glucose tolerance, and in vivo antidiabetic effect along with the evaluation of gene expressions involved in diabetes mellitus were carried out. Significant quantities of phenolic (71.208 ± 2.89 mgg-1 GAE) and flavonoid (26.38 ± 3.53 mgg-1 QE) were present. Inhibitory concentration (IC50) of the plant extract exhibited an excellent in vitro antioxidant (IC50 = 33.81 µg/mL) and α-amylase (IC50 = 12.18 µg/mL) inhibitory potential. The HPLC analysis confirmed the gallic acid (257.79 mgg-1) as main constituent of the extract followed by kaempferol (22.86 mgg-1), myricetin (0.16 mgg-1), and quercetin (3.22 mgg-1). Ethanolic extract displayed glucose tolerance in normo-glycemic rats. Streptozotocin-induced hyperglycemia declined dose dependently in the extract treated rats with improvement in lipid profile and liver and renal function biomarkers. The F. johannis-treated groups showed an increase in mRNA expressions of glucose transporter 4 (GLUT-4), glucokinase, insulin growth like factor 1 and peroxisomal proliferator activating receptor gamma in pancreas. However, the Glucose-6-phosphatase was downregulated. Present study suggests that the ethanolic extract of F. johannis leaves demonstrates a good anti-diabetic profile by improving insulin sensitivity, GLUT-4 translocation, and carbohydrate metabolism while inhibiting lipogenesis.


Asunto(s)
Diabetes Mellitus Experimental , Ficus , Hiperglucemia , Extractos Vegetales , Animales , Ratas , alfa-Amilasas , Antioxidantes/farmacología , Glucemia/metabolismo , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/tratamiento farmacológico , Etanol , Ficus/química , Ficus/metabolismo , Flavonoides/farmacología , Glucosa , Hiperglucemia/tratamiento farmacológico , Hipoglucemiantes/farmacología , Hipoglucemiantes/uso terapéutico , Fenoles , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Estreptozocina , Quinasas del Centro Germinal/efectos de los fármacos , Transportador de Glucosa de Tipo 4/efectos de los fármacos , Factor I del Crecimiento Similar a la Insulina/efectos de los fármacos , Glucosa-6-Fosfatasa/efectos de los fármacos
2.
Asian Pac J Cancer Prev ; 22(3): 843-852, 2021 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-33773549

RESUMEN

BACKGROUND: Drug synergy is the combine effect of drug efficacy. Synergistic combinations of active ingredients have proven to be highly effective and more useful in therapeutics. In contrast, the individual effect of drug is usually undesirable and mostly used for selecting drug-resistant mutations. Purpose of this study was to check synergistic effects of both plants (Barbadensis miller and Marsdenia condurango) against liver and cervical cancer. METHODOLOGY: Culturing of HeLa (cervical cancer cell line) and HepG2 (liver cancer cell line) cells, IC50 evaluation, viability assays (trypan blue, crystal violet), p53 ELISA and immunocytochemistry, MUSE analysis (count and viability), antioxidants (GSH, SOD, CAT), at the end RT-PCR was performed. RESULTS: IC50 evaluation was done of each plant individually and with combination for synergistic effects, IC50 with plants combination (synergism) was applied on further viability assays (trypan blue, crystal violet, MUSE analysis via count and viability kit) p53 ELISA and immunocytochemistry for evaluation of cellular apoptosis, antioxidants assays (GSH, SOD, CAT), and RT-PCR with proliferative and apoptotic markers along with internal control. CONCLUSION: According to current study it was observed that synergistic effect of these plants has more anticancer properties with minimum effective dose. It was also observed that extracts possess the ability to induce apoptosis, restrict proliferation and enhanced oxidative stress.


Asunto(s)
Aloe , Apoptosis/efectos de los fármacos , Carcinoma Hepatocelular , Proliferación Celular/efectos de los fármacos , Neoplasias Hepáticas , Marsdenia , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Neoplasias del Cuello Uterino , Catalasa/efectos de los fármacos , Catalasa/metabolismo , Supervivencia Celular/efectos de los fármacos , Sinergismo Farmacológico , Femenino , Glutatión/efectos de los fármacos , Glutatión/metabolismo , Células HeLa , Células Hep G2 , Humanos , Concentración 50 Inhibidora , Fitoterapia , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Proteína p53 Supresora de Tumor/efectos de los fármacos , Proteína p53 Supresora de Tumor/metabolismo
3.
Curr Pharm Biotechnol ; 21(11): 1059-1069, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32065099

RESUMEN

BACKGROUND: The folkloric profile of Delonix regia demonstrates that it can be used in the management of diabetes. OBJECTIVE: The present study was conducted to evaluate the safety profile of the aerial part extracts of Delonix regia and their antidiabetic potential along with improvement in oxidative stress. MATERIALS AND METHODS: Phytochemical screening, total phenolic, and flavonoid contents along with in-vitro antioxidant and alpha-amylase inhibitory activities were determined. HPLC analysis, acute toxicity, glucose tolerance, in-vivo antidiabetic effect along with the influence on biochemical, oxidative stress parameters, and comet assay of the active extract were performed and assessed. RESULTS: Total phenolic (831.6±0.002 mg/g GAE) and flavonoid (361.4±0.002 mg/g QE) contents were found to be higher in the methanolic extract. Inhibitory concentration IC50 indicated better results for the methanolic extract in DPPH (47.6µg/mL) and alpha-amylase inhibitory (14.61µg/mL) assays. HPLC analysis of the methanolic extract confirmed the presence of quercetin, gallic acid, caffeic acid, cinnamic acid, ferulic acid, and p-coumaric acid. Acute oral toxicity exhibited no mortality and morbidity during the 24h period. The methanolic extract showed better tolerance to glucose. Streptozotocin- nicotinamide (55-110 mg/kg) induced hyperglycemia declined along with improvement in hematological, biochemical parameters and oxidative stress markers (SOD, CAT, H202) in a dose-dependent manner. The maximum effect was recorded at 500mg/kg dose. Comet assay was performed for genotoxic studies and it was observed that the methanolic extract of Delonix regia showed the maximum genoprotective effect at 100µg/mL. CONCLUSION: The findings suggest that the methanolic aerial part extract of Delonix regia exhibited hypoglycemic, antioxidant, and hypolipidemic activities. The antidiabetic effect was comparable to glibenclamide suggesting its therapeutic use as a natural anti-diabetic remedy.


Asunto(s)
Antioxidantes/uso terapéutico , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Fabaceae/química , Hipoglucemiantes/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/uso terapéutico , Animales , Antioxidantes/administración & dosificación , Antioxidantes/toxicidad , Daño del ADN , Relación Dosis-Respuesta a Droga , Hiperglucemia/tratamiento farmacológico , Hipoglucemiantes/aislamiento & purificación , Hipoglucemiantes/toxicidad , Medicina Tradicional , Componentes Aéreos de las Plantas/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/toxicidad , Ratas Wistar
4.
Curr Pharm Biotechnol ; 20(15): 1288-1308, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31433749

RESUMEN

BACKGROUND: Natural product with apoptotic activity could serve as a potential new source for anti-cancer medicine. Numerous phytochemicals from plants have shown to exert antineoplastic effects via programmed cell death (apoptosis). Cancer is one of the leading causes of death in prosperous countries. The subject study was intended to evaluate the anticancer properties of Kalonji extracts against cancer cell lines HeLa and HepG2 and normal cell lines BHK and VERO were used as normal controls. MATERIALS & METHODS: For the evaluation of anti-proliferative effects, cell viability and cell death in all groups of cells were evaluated via MTT, crystal violet and trypan blue assays. For the evaluation of angiogenesis, Immunocytochemistry and ELISA of VEGF were done. Immunocytochemistry and ELISA of Annexin-V and p53 were performed for the estimation of apoptosis in all groups of cells. Furthermore, LDH assay, antioxidant enzymes activity (GSH, APOX, CAT and SOD) and RT-PCR with proliferative and apoptotic markers along with internal control were also performed. Cancer cells of both cell lines HepG2 and HeLa cells showed reduced viability, angiogenesis and proliferation with increased apoptosis when treated with Kalonji extracts. Whereas anti-oxidative enzymes show enhanced levels in treated cancer cells as compared to untreated ones. CONCLUSION: It was observed that Kalonji extracts have the ability to induce apoptosis and improve the antioxidant status of HeLa and HepG2 cells. They can also inhibit the proliferation and angiogenesis in both these cancer cell lines.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Antioxidantes/metabolismo , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Nigella sativa/química , Extractos Vegetales/farmacología , Animales , Antineoplásicos Fitogénicos/aislamiento & purificación , Bioensayo , Supervivencia Celular/efectos de los fármacos , Chlorocebus aethiops , Células HeLa , Células Hep G2 , Humanos , Extractos Vegetales/aislamiento & purificación , Transcriptoma/efectos de los fármacos , Factor A de Crecimiento Endotelial Vascular/genética , Células Vero
5.
BMC Complement Altern Med ; 17(1): 265, 2017 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-28506259

RESUMEN

BACKGROUND: Emerging drug resistance and hindrance of treatment is provoking scientists to search new, less expensive medicinally active compounds. Dental diseases caused by oral pathogens are very frequent chronic infections around the world. The medical potentials of a lot of Pakistani local herbs and herbal combinations is relatively unknown, hence attempted to explore. A study was designed to investigate potential role of local medicinal herbs for example Miswak, Kalonji & Aloe vera as antimicrobial, antioxidant and anti-proliferative agents against oral pathogens and cancer cell line. METHODS: Medicinal extracts were prepared in solvents of different polarities. Their antimicrobial activity was determined alone and in combination against oral pathogens. Antioxidant activity was evaluated through Catalase and Superoxide dismutase assay and anti-proliferative activity was evaluated through 3-(4, 5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide) assay. RESULTS: Plant extracts alone and in combinations were found significantly effective as antimicrobial agent against standard ATCC strains of C. albicans and S. aureus (P ˂0.001). Especially Miwak extract was found highly significant against fungus. Extracts of Kalonji were found significant in inhibiting growth of HeLa cell lines. Miswak and Kalonji showed significant levels of antioxidant activity. CONCLUSION: Medicinal herbs Miswak and Kalonji have potential to be used for therapeutic purposes. Results suggested that herbal medicinal composition can be prepared using these extracts after applying scientific standardization methods.


Asunto(s)
Aloe/química , Antiinfecciosos/farmacología , Candida albicans/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Enfermedades de la Boca/microbiología , Nigella sativa/química , Extractos Vegetales/farmacología , Staphylococcus aureus/efectos de los fármacos , Antiinfecciosos/análisis , Antioxidantes/análisis , Antioxidantes/farmacología , Candida albicans/fisiología , Línea Celular Tumoral , Humanos , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/análisis , Plantas Medicinales/química , Staphylococcus aureus/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA